Marengo Therapeutics

Marengo Therapeutics is a clinical stage biotechnology company based in Cambridge, Massachusetts. The company employs 33 people. Marengo Therapeutics is pioneering a novel approach to cancer treatment by activating the body's immune system. Their unique therapeutic platform selectively enhances T cells, boosting their anti-tumor activity and promoting long-term immunity to combat cancer. The company's focus on immunotherapy sets it apart in the field of cancer treatment. Their platform aims to provide a rapid, effective, and durable response against cancer, offering a potentially transformative approach to fighting the disease. For more information about Marengo Therapeutics and their innovative cancer therapies, visit their website at www.marengotx.com.